Calls Now Open

2024 ADDF-Harrington + 2025 Harrington Scholar-Innovator Programs

You've just added:

Translational Research in Cancer Treatments: Webinar


Date + Time

  • April 20, 2023

    12:00 pm - 1:00 pm

  • EST

Scientists around the world are working with Harrington Discovery Institute on diverse therapeutic approaches to treat cancer. As patients and their families look to be part of the solution through their charitable donations, the field of philanthropy in particular has played a large role in advancing medical discoveries.

The Morgan Stanley GIFT Cures program provides opportunities for new and veteran philanthropists to combine their resources to magnify the impact of their medically related giving, whether they wish to focus on a specific disease or across a broader spectrum. It is an opportunity for philanthropists, foundations, family offices and companies interested in learning collaboratively from drug development experts and providing catalytic support to bring cures and treatments to market.

Learn of scientific breakthroughs that Harrington is advancing on the path towards approved treatments for cancer at rapid pace. With all of these drug development efforts, the goal is the same: To translate scientific discovery into real-world therapies. In months and years, not decades. Join our efforts to create cures.

Hear from speakers including:

  • Seth Field, MD: Harrington Discovery Institute Investigator and 2017 Harrington Scholar-Innovator
  • Kim Henderson, MD: Head of Wealth Management Health and Wellness Education, Morgan Stanley
  • Melanie Schnoll Begun: Head of Family Office Resources Field Engagement, Morgan Stanley
  • Diana Wetmore, PhD: Vice President, Therapeutics Development Center, Harrington Discovery Institute

Translational Research in Cancer Treatments: Webinar

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.